VYNE Therapeutics Inc.
VYNE Therapeutics Inc., a biopharmaceutical company headquartered in the United States, is dedicated to developing innovative therapies for patients with unmet medical needs. Founded in 2017, VYNE focuses on dermatology and immunology, leveraging its proprietary drug delivery technologies to create unique formulations that enhance treatment efficacy. The company’s flagship product, Amzeeq, is a topical minocycline formulation that addresses acne vulgaris, showcasing VYNE's commitment to advancing patient care through novel solutions. With a strong market position, VYNE Therapeutics has achieved significant milestones, including successful product launches and strategic partnerships, solidifying its reputation as a leader in the biopharmaceutical industry.
DitchCarbon Score
How does VYNE Therapeutics Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
VYNE Therapeutics Inc.'s score of 13 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
VYNE Therapeutics Inc.'s reported carbon emissions
VYNE Therapeutics Inc., headquartered in the US, currently does not have publicly available carbon emissions data for recent years, as indicated by the absence of specific emissions figures. Furthermore, there are no documented reduction targets or climate pledges outlined by the company. In the context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and climate commitments, often setting ambitious targets to reduce their carbon footprints across Scope 1, 2, and 3 emissions. However, without specific data or commitments from VYNE Therapeutics, it is unclear how they are addressing climate change or contributing to emissions reduction efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
VYNE Therapeutics Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
